214 related articles for article (PubMed ID: 17482163)
21. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
22. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
[TBL] [Abstract][Full Text] [Related]
23. Zinc in the spinal cord of a mutant SOD1 mouse model of ALS.
Pamphlett R; Kum-Jew S
Neuroreport; 2003 Mar; 14(4):547-9. PubMed ID: 12657882
[TBL] [Abstract][Full Text] [Related]
24. Altered macroautophagy in the spinal cord of SOD1 mutant mice.
Li L; Zhang X; Le W
Autophagy; 2008 Apr; 4(3):290-3. PubMed ID: 18196963
[TBL] [Abstract][Full Text] [Related]
25. ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.
Lemarchant S; Pomeshchik Y; Kidin I; Kärkkäinen V; Valonen P; Lehtonen S; Goldsteins G; Malm T; Kanninen K; Koistinaho J
Mol Neurodegener; 2016 Jan; 11():10. PubMed ID: 26809777
[TBL] [Abstract][Full Text] [Related]
26. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Hong Y; Taylor DM; Minotti S; Figlewicz DA; Durham HD
J Neurochem; 2008 Jun; 105(6):2353-66. PubMed ID: 18315558
[TBL] [Abstract][Full Text] [Related]
27. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
28. Aldehyde Dehydrogenases 1A2 Expression and Distribution are Potentially Associated with Neuron Death in Spinal Cord of Tg(SOD1*G93A)1Gur Mice.
Liang H; Wu C; Deng Y; Zhu L; Zhang J; Gan W; Tang C; Xu R
Int J Biol Sci; 2017; 13(5):574-587. PubMed ID: 28539831
[TBL] [Abstract][Full Text] [Related]
29. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
[TBL] [Abstract][Full Text] [Related]
30. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
[TBL] [Abstract][Full Text] [Related]
31. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Kaiser M; Maletzki I; Hülsmann S; Holtmann B; Schulz-Schaeffer W; Kirchhoff F; Bähr M; Neusch C
J Neurochem; 2006 Nov; 99(3):900-12. PubMed ID: 16925593
[TBL] [Abstract][Full Text] [Related]
32. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
Chen X; Zhang X; Li C; Guan T; Shang H; Cui L; Li XM; Kong J
J Neurochem; 2013 Jan; 124(1):45-58. PubMed ID: 23043510
[TBL] [Abstract][Full Text] [Related]
33. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1
Mallozzi C; Spalloni A; Longone P; Domenici MR
Neural Plast; 2018; 2018():2430193. PubMed ID: 30154836
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology.
Son M; Puttaparthi K; Kawamata H; Rajendran B; Boyer PJ; Manfredi G; Elliott JL
Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6072-7. PubMed ID: 17389365
[TBL] [Abstract][Full Text] [Related]
36. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.
Urushitani M; Sik A; Sakurai T; Nukina N; Takahashi R; Julien JP
Nat Neurosci; 2006 Jan; 9(1):108-18. PubMed ID: 16369483
[TBL] [Abstract][Full Text] [Related]
37. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
38. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
Turner BJ; Parkinson NJ; Davies KE; Talbot K
Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
[TBL] [Abstract][Full Text] [Related]
39. Impaired proteasome function in sporadic amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Strong MJ; Durham HD
Amyotroph Lateral Scler; 2012 Jun; 13(4):367-71. PubMed ID: 22632443
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
